Insider Trading activities of Varian Medical Systems Inc insiders. , Part 5

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Varian Medical Systems Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Varian Medical Systems Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Varian Medical Systems Inc since 2005. The reporting company's ticker symbol is VAR. The reporting company's CIK number is 203527.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $642,133,665.
The total value of stock option exercises since 2005 is $312,832,236.



Table 2. Detailed insider stock purchases, sales, and option exercises of Varian Medical Systems Inc insiders (VAR) , Part 5
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-05-18 Finney Elisha W (Exec VP and CFO) Option Ex 3,704 .00 0
2012-05-02 Finney Elisha W (Exec VP and CFO) Sale 6,000 64.95 389,700
2012-05-02 Finney Elisha W (Exec VP and CFO) Option Ex 5,000 37.17 185,850
2012-05-01 Finney Elisha W (Exec VP and CFO) Sale 4,000 64.12 256,483
2012-05-01 Finney Elisha W (Exec VP and CFO) Option Ex 4,000 39.85 159,400
2012-04-02 Finney Elisha W (Exec VP and CFO) Sale 10,000 69.08 690,840
2012-04-02 Finney Elisha W (Exec VP and CFO) Option Ex 9,000 38.51 346,590
2012-03-26 Wilson Dow R (EVP and COO) Sale 10,000 69.42 694,230
2012-03-26 Wilson Dow R (EVP and COO) Option Ex 10,000 37.17 371,700
2012-03-26 Guertin Timothy E (President and CEO) Sale 50,000 69.43 3,471,400
2012-03-26 Guertin Timothy E (President and CEO) Option Ex 50,000 49.88 2,494,000
2012-03-14 Finney Elisha W (Exec VP and CFO) Sale 2,000 69.95 139,900
2012-03-01 Finney Elisha W (Exec VP and CFO) Sale 10,000 65.59 655,860
2012-03-01 Finney Elisha W (Exec VP and CFO) Option Ex 9,000 38.51 346,590
2012-02-21 Laret Mark R (Director) Sale 2,691 66.11 177,915
2012-02-14 Naumann-etienne Ruediger (Director) Sale 2,691 65.61 176,569
2012-02-13 Thyagarajan Venkatraman (Director) Option Ex 2,691 .00 0
2012-02-13 Laret Mark R (Director) Option Ex 2,691 .00 0
2012-02-13 Kuo John W (VP, Gen Counsel and Secretary) Sale 1,112 65.40 72,727
2012-02-13 Kuo John W (VP, Gen Counsel and Secretary) Option Ex 1,112 37.17 41,333
2012-02-13 Naumann-etienne Ruediger (Director) Option Ex 2,691 .00 0
2012-02-13 Eckert R Andrew (Director) Option Ex 2,691 .00 0
2012-02-13 Brown John Seely (Director) Option Ex 2,691 .00 0
2012-02-13 Bostrom Susan L (Director) Option Ex 2,691 .00 0
2012-02-09 Martin David W Jr (Director) Option Ex 6,204 .00 0
2012-02-03 Eckert R Andrew (Director) Sale 6,790 67.82 460,497
2012-02-03 Eckert R Andrew (Director) Option Ex 5,000 47.58 237,900
2012-02-01 Finney Elisha W (SVP, Finance and CFO) Sale 10,000 66.42 664,180
2012-02-01 Finney Elisha W (SVP, Finance and CFO) Option Ex 9,000 38.51 346,590
2012-01-13 Kuo John W (VP, Gen Counsel and Secretary) Sale 1,111 70.36 78,167
2012-01-13 Kuo John W (VP, Gen Counsel and Secretary) Option Ex 1,111 37.17 41,295
2012-01-12 Chen Tai-yun (VP and Corporate Controller) Sale 18,077 71.00 1,283,467
2012-01-12 Chen Tai-yun (VP and Corporate Controller) Option Ex 13,333 52.83 704,382
2012-01-12 Finney Elisha W (SVP, Finance and CFO) Sale 2,000 69.95 139,900
2012-01-03 Chen Tai-yun (VP and Corporate Controller) Sale 37,450 68.83 2,577,795
2012-01-03 Chen Tai-yun (VP and Corporate Controller) Option Ex 37,450 56.47 2,114,614
2012-01-03 Kuo John W (VP, Gen Counsel and Secretary) Sale 6,666 68.00 453,288
2012-01-03 Kuo John W (VP, Gen Counsel and Secretary) Option Ex 6,666 52.83 352,164
2012-01-03 Finney Elisha W (SVP, Finance and CFO) Sale 10,000 68.89 688,930
2012-01-03 Finney Elisha W (SVP, Finance and CFO) Option Ex 9,000 38.51 346,590
2011-12-30 Chen Tai-yun (VP and Corporate Controller) Sale 14,074 67.17 945,350
2011-12-30 Chen Tai-yun (VP and Corporate Controller) Option Ex 14,074 37.17 523,130
2011-12-30 Guertin Timothy E (President and CEO) Sale 100,000 67.00 6,700,000
2011-12-30 Guertin Timothy E (President and CEO) Option Ex 100,000 49.88 4,988,000
2011-12-27 Kuo John W (VP, Gen Counsel and Secretary) Sale 11,249 66.50 748,058
2011-12-27 Kuo John W (VP, Gen Counsel and Secretary) Option Ex 11,249 52.61 591,809
2011-12-22 Kuo John W (VP, Gen Counsel and Secretary) Sale 57,778 65.56 3,787,983
2011-12-22 Kuo John W (VP, Gen Counsel and Secretary) Option Ex 57,778 46.81 2,704,761
2011-12-20 Finney Elisha W (SVP, Finance and CFO) Sale 6,000 64.95 389,700
2011-12-20 Finney Elisha W (SVP, Finance and CFO) Option Ex 5,000 37.17 185,850
2011-12-14 Finney Elisha W (SVP, Finance and CFO) Sale 4,000 63.38 253,528
2011-12-14 Finney Elisha W (SVP, Finance and CFO) Option Ex 4,000 39.85 159,400
2011-12-13 Kluge Robert H (Corp VP; Pres. X-Ray Products) Sale 15,483 65.00 1,006,395
2011-11-15 Naumann-etienne Ruediger (Director) Sale 1,901 60.75 115,489
2011-11-07 Finney Elisha W (SVP, Finance and CFO) Sale 5,000 58.00 290,000
2011-11-07 Finney Elisha W (SVP, Finance and CFO) Option Ex 5,000 39.85 199,250
2011-11-04 Finney Elisha W (SVP, Finance and CFO) Sale 10,000 58.00 580,000
2011-11-04 Finney Elisha W (SVP, Finance and CFO) Option Ex 10,000 .00 0
2011-08-05 Finney Elisha W (SVP, Finance and CFO) Sale 5,000 58.00 290,000
2011-08-05 Finney Elisha W (SVP, Finance and CFO) Option Ex 5,000 39.85 199,250
2011-07-05 Finney Elisha W (SVP, Finance and CFO) Sale 10,000 70.61 706,090
2011-07-05 Finney Elisha W (SVP, Finance and CFO) Option Ex 10,000 39.85 398,500
2011-07-01 Kuo John W (VP, Gen Counsel and Secretary) Sale 30,950 70.67 2,187,329
2011-07-01 Kuo John W (VP, Gen Counsel and Secretary) Option Ex 23,750 47.54 1,129,003
2011-06-27 Guertin Timothy E (President and CEO) Sale 50,000 68.28 3,413,900
2011-06-27 Guertin Timothy E (President and CEO) Option Ex 50,000 49.88 2,494,000
2011-06-13 Wilson Dow R (EVP and Pres. Oncology Sys.) Sale 2,315 66.16 153,153
2011-06-13 Wilson Dow R (EVP and Pres. Oncology Sys.) Option Ex 2,315 37.17 86,048
2011-06-06 Finney Elisha W (SVP, Finance and CFO) Sale 10,000 65.42 654,170
2011-06-06 Finney Elisha W (SVP, Finance and CFO) Option Ex 10,000 39.85 398,500
2011-05-19 Wilson Dow R (EVP and Pres. Oncology Sys.) Sale 3,188 68.78 219,264
2011-05-18 Chen Tai-yun (VP and Corporate Controller) Option Ex 1,481 .00 0
2011-05-18 Kuo John W (VP, Gen Counsel and Secretary) Option Ex 2,222 .00 0
2011-05-18 Wilson Dow R (EVP and Pres. Oncology Sys.) Option Ex 5,796 .00 0
2011-05-18 Kluge Robert H (Corp VP; Pres. X-Ray Products) Option Ex 3,704 .00 0
2011-05-18 Guertin Timothy E (President and CEO) Option Ex 11,111 .00 0
2011-05-18 Finney Elisha W (SVP, Finance and CFO) Option Ex 3,704 .00 0
2011-05-13 Wilson Dow R (EVP and Pres. Oncology Sys.) Sale 2,315 69.54 160,982
2011-05-13 Wilson Dow R (EVP and Pres. Oncology Sys.) Option Ex 2,315 37.17 86,048
2011-05-06 Eckert R Andrew (Director) Sale 8,000 70.46 563,672
2011-05-06 Eckert R Andrew (Director) Option Ex 8,000 49.74 397,920
2011-05-05 Laret Mark R (Director) Sale 1,901 69.95 132,984
2011-05-05 Finney Elisha W (SVP, Finance and CFO) Sale 10,000 69.63 696,270
2011-05-05 Finney Elisha W (SVP, Finance and CFO) Option Ex 10,000 39.85 398,500
2011-05-02 Guertin Timothy E (President and CEO) Sale 40,000 70.44 2,817,720
2011-05-02 Guertin Timothy E (President and CEO) Option Ex 40,000 39.85 1,594,000
2011-04-20 Kluge Robert H (Corp VP; Pres. X-Ray Products) Sale 30,000 70.00 2,100,000
2011-04-20 Kluge Robert H (Corp VP; Pres. X-Ray Products) Option Ex 30,000 52.61 1,578,300
2011-04-13 Wilson Dow R (EVP and Pres. Oncology Sys.) Sale 2,315 69.17 160,140
2011-04-13 Wilson Dow R (EVP and Pres. Oncology Sys.) Option Ex 2,315 37.17 86,048
2011-04-05 Finney Elisha W (SVP, Finance and CFO) Sale 10,000 68.92 689,150
2011-04-05 Finney Elisha W (SVP, Finance and CFO) Option Ex 10,000 35.97 359,720
2011-03-21 Levy Richard M (Director) Sale 15,000 66.00 990,000
2011-03-21 Levy Richard M (Director) Option Ex 15,000 32.09 481,425
2011-03-14 Wilson Dow R (EVP and Pres. Oncology Sys.) Sale 2,315 66.31 153,505
2011-03-14 Wilson Dow R (EVP and Pres. Oncology Sys.) Option Ex 2,315 37.17 86,048
2011-03-07 Levy Richard M (Director) Sale 15,000 70.23 1,053,510
2011-03-07 Levy Richard M (Director) Option Ex 15,000 32.09 481,425
2011-03-07 Finney Elisha W (SVP, Finance and CFO) Sale 10,000 70.11 701,050
2011-03-07 Finney Elisha W (SVP, Finance and CFO) Option Ex 10,000 32.09 320,950
2011-02-22 Levy Richard M (Director) Sale 15,000 68.21 1,023,149
2011-02-22 Levy Richard M (Director) Option Ex 15,000 32.09 481,425
2011-02-16 Wilson Dow R (EVP and Pres. Oncology Sys.) Sale 5,044 70.83 357,261
2011-02-16 Naumann-etienne Ruediger (Director) Sale 13,000 70.69 918,970
2011-02-16 Naumann-etienne Ruediger (Director) Option Ex 13,000 48.66 632,580
2011-02-15 Laret Mark R (Director) Option Ex 1,901 .00 0
2011-02-15 Naumann-etienne Ruediger (Director) Option Ex 1,901 .00 0
2011-02-15 Martin David W Jr (Director) Option Ex 1,901 .00 0
2011-02-15 Eckert R Andrew (Director) Option Ex 1,901 .00 0
2011-02-15 Brown John Seely (Director) Option Ex 1,901 .00 0
2011-02-15 Bostrom Susan L (Director) Option Ex 1,901 .00 0
2011-02-14 Wilson Dow R (EVP and Pres. Oncology Sys.) Sale 2,314 70.36 162,806
2011-02-14 Wilson Dow R (EVP and Pres. Oncology Sys.) Option Ex 2,314 37.17 86,011
2011-02-08 Kluge Robert H (Corp VP; Pres. X-Ray Products) Sale 20,000 68.00 1,360,000
2011-02-08 Kluge Robert H (Corp VP; Pres. X-Ray Products) Option Ex 20,000 50.66 1,013,199
2011-02-07 Levy Richard M (Director) Sale 15,000 67.71 1,015,590
2011-02-07 Levy Richard M (Director) Option Ex 15,000 32.09 481,425
2011-02-07 Kluge Robert H (Corp VP; Pres. X-Ray Products) Sale 49,875 67.70 3,376,687
2011-02-07 Kluge Robert H (Corp VP; Pres. X-Ray Products) Option Ex 49,875 50.27 2,507,216
2011-02-07 Finney Elisha W (SVP, Finance and CFO) Sale 10,000 67.70 677,050
2011-02-07 Finney Elisha W (SVP, Finance and CFO) Option Ex 10,000 32.09 320,950
2011-01-31 Levy Richard M (Director) Sale 30,000 68.27 2,048,040
2011-01-31 Levy Richard M (Director) Option Ex 30,000 32.09 962,850
2011-01-31 Guertin Timothy E (President and CEO) Sale 90,000 68.32 6,148,528
2011-01-31 Guertin Timothy E (President and CEO) Option Ex 90,000 39.85 3,586,500
2011-01-13 Wilson Dow R (EVP and Pres. Oncology Sys.) Sale 2,315 69.81 161,619
2011-01-13 Wilson Dow R (EVP and Pres. Oncology Sys.) Option Ex 2,315 37.17 86,048
2011-01-10 Levy Richard M (Director) Sale 15,000 68.15 1,022,310
2011-01-10 Levy Richard M (Director) Option Ex 15,000 32.09 481,425
2011-01-05 Finney Elisha W (SVP, Finance and CFO) Sale 10,000 69.52 695,210
2011-01-05 Finney Elisha W (SVP, Finance and CFO) Option Ex 10,000 32.09 320,950
2010-12-28 Kuo John W (VP, Gen Counsel and Secretary) Sale 17,318 70.66 1,223,689
2010-12-28 Kuo John W (VP, Gen Counsel and Secretary) Option Ex 17,318 50.66 877,329
2010-12-27 Kuo John W (VP, Gen Counsel and Secretary) Sale 56,015 70.63 3,956,115
2010-12-27 Kuo John W (VP, Gen Counsel and Secretary) Option Ex 56,015 45.90 2,571,256
2010-12-27 Levy Richard M (Director) Sale 15,000 70.59 1,058,880
2010-12-27 Levy Richard M (Director) Option Ex 15,000 32.09 481,425
2010-12-16 Chen Tai-yun (VP and Corporate Controller) Sale 7,500 69.32 519,899
2010-12-16 Chen Tai-yun (VP and Corporate Controller) Option Ex 7,500 60.32 452,400
2010-12-13 Wilson Dow R (EVP and Pres. Oncology Sys.) Sale 20,926 67.83 1,419,494
2010-12-13 Wilson Dow R (EVP and Pres. Oncology Sys.) Option Ex 20,926 37.17 777,819
2010-12-13 Levy Richard M (Director) Sale 15,000 67.83 1,017,465
2010-12-13 Levy Richard M (Director) Option Ex 15,000 32.09 481,425
2010-12-06 Kuo John W (VP, Gen Counsel and Secretary) Sale 10,061 69.05 694,691
2010-12-06 Wilson Dow R (EVP and Pres. Oncology Sys.) Sale 28,073 69.05 1,938,328
2010-12-06 Wilson Dow R (EVP and Pres. Oncology Sys.) Option Ex 28,073 40.57 1,138,921
2010-12-06 Finney Elisha W (SVP, Finance and CFO) Sale 10,000 69.05 690,520
2010-12-06 Finney Elisha W (SVP, Finance and CFO) Option Ex 10,000 32.09 320,950
2010-12-02 Kluge Robert H (Corp VP; Pres. X-Ray Products) Sale 20,000 68.00 1,360,000
2010-12-02 Kluge Robert H (Corp VP; Pres. X-Ray Products) Option Ex 20,000 49.88 997,600

Insider trading activities including stock purchases, stock sales, and option exercises of VAR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Varian Medical Systems Inc (symbol VAR, CIK number 203527) see the Securities and Exchange Commission (SEC) website.